908 Devices INC Form 4 insider transactions

Kolawole A. Otitoju, Chief Business & Strategy Officer at 908 Devices Inc., was granted stock options and restricted stock units.

Kevin J. McCallion, SVP of Products and Production at 908 Devices Inc., reported transactions involving the sale of common stock and exercise of stock options under a pre-arranged trading plan.

Kevin J. McCallion, SVP of Products and Production at 908 Devices Inc., reported transactions involving the sale of common stock and the exercise of stock options under a pre-arranged trading plan.

Christopher D. Brown, a Director at 908 Devices Inc., has sold a total of 40,000 shares of common stock across three transactions executed between April 8th and April 10th, 2026, under a pre-established Rule 10b5-1 trading plan.

908 Devices Inc.'s SVP of Products and Production, Kevin J. McCallion, reported the exercise of stock options and subsequent sale of an equal number of common shares under a 10b5-1 plan.

Kevin J. McCallion, SVP of Products and Production at 908 Devices Inc., has filed a Form 4 indicating a planned sale of 7 shares of common stock on March 2, 2026, under a Rule 10b5-1 trading plan.

908 Devices Inc. Director Christopher D. Brown converted Restricted Stock Units into common stock on February 1, 2026, increasing his direct share ownership.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the vesting of restricted stock units, a new stock option grant, and a 'sell to cover' transaction for tax obligations.

908 Devices CFO Joseph H. Griffith IV reported the settlement of Restricted Stock Units, a subsequent 'sell to cover' transaction for tax obligations, and new grants of RSUs and stock options.

908 Devices Inc. Director Mark Spoto disclosed recent changes in his beneficial ownership of common stock, including direct and indirect holdings.

Joseph H. Griffith IV, Chief Financial Officer of 908 Devices Inc., sold 5,000 shares of common stock in early October 2025 through a pre-arranged Rule 10b5-1 trading plan.

Joseph H. Griffith IV, CFO of 908 Devices Inc., reported the sale of 5,000 common shares under a Rule 10b5-1 plan.

A director at 908 Devices Inc. was granted restricted stock units and stock options, with vesting commencing in August 2025.

Michele M. Leonhart, a Director at 908 Devices Inc., acquired 6,485 shares of common stock through the settlement of Restricted Stock Units.

Michael S. Turner, Chief Legal & Admin Officer of 908 Devices Inc., has sold a total of 24,603 shares of common stock over three days in June 2025, pursuant to a Rule 10b5-1 trading plan.

908 Devices Inc. Director Michele M. Leonhart was granted 14,083 Restricted Stock Units and options to purchase 6,516 shares of common stock on June 12, 2025, aligning her interests with long-term shareholder value.

E. Kevin Hrusovsky, a Director at 908 Devices Inc., reported the vesting and conversion of 11,364 Restricted Stock Units into common stock, alongside the grant of 14,083 new RSUs and 6,516 stock options.

A recent SEC Form 4 filing details Director Anthony Hunt's acquisition of new Restricted Stock Units and stock options, alongside the settlement of previously vested RSUs, at 908 Devices Inc.

Director Jeffrey P. George of 908 Devices Inc. reported the settlement of vested Restricted Stock Units into common stock and the grant of new RSUs and stock options.

Fenel M. Eloi, a Director at 908 Devices Inc., reported the vesting of 11,364 Restricted Stock Units into common stock and the acquisition of new grants including 14,083 Restricted Stock Units and 6,516 stock options.

Marcia Eisenberg, a Director at 908 Devices Inc., increased her direct beneficial ownership by 11,364 shares of common stock following the scheduled vesting of Restricted Stock Units.

Keith Crandell, a Director and 10% owner of 908 Devices Inc., reported recent equity transactions including the vesting of Restricted Stock Units and the grant of new RSUs and stock options.

Mark Spoto, a Director at 908 Devices Inc., reported the settlement of previously vested Restricted Stock Units and the grant of new RSUs and stock options.

Joseph H. Griffith IV, Chief Financial Officer of 908 Devices Inc., reported the sale of 6,940 shares of common stock for approximately $49,123, executed under a Rule 10b5-1 trading plan.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reports the purchase and indirect ownership of company stock.

Director Mark Spoto recently purchased additional shares of 908 Devices Inc., increasing his direct and indirect holdings.

Kevin Knopp, CEO of 908 Devices, reports a recent share purchase and details of indirect ownership through a trust.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reports acquisition of stock options and restricted stock units.

Chief Financial Officer of 908 Devices Inc., Joseph H. Griffith IV, reports acquisition of stock options and restricted stock units.

Michael S. Turner, Chief Legal & Admin Officer of 908 Devices Inc., reports the acquisition of stock options and restricted stock units.